Biologics Making Steady Inroads Into Device Landscape, Says MedCap Advisors CEO Christopher Velis
9/26/2012 8:59:13 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today issued a discussion paper focused on the market penetration of biologics. The paper, “Biologics Revolution: Breaking down barriers to entry for advanced biologic solutions,” captures MedCap CEO Christopher Velis’ insights from the field.
comments powered by